FDA Issues CRL to Dibutepinephrine (Anaphylm) Sublingual Film for Type 1 Allergic Reactions
The CRL cited deficiencies limited to packaging and administration, with resubmission expected as early as Q3 2026.
UTHSC In the Media
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on January 30, 2026 for the New Drug Application (NDA)… Read More
Doctors share the best ways to get the most from a bidet
Once considered an oddity in American homes, bidets are becoming increasingly common as more people seek a hygienic and sustainable alternative to toilet paper or a hand managing certain physical conditions.
Doctors share the best ways to get the most from a bidet
Bidets once were considered an oddity in American homes
Doctors share the best ways to get the most from a bidet
Bidets once were considered an oddity in American homes
SPRINT’s intensive therapy benefit fades once BP creeps back up
The substantial reductions in cardiovascular disease (CVD) and all-cause mortality achieved with intensive blood pressure lowering in the landmark SPRINT trial were not sustained in a newly released long-term follow-up.
University of Tennessee Health Science Center College of Medicine names neurosurgery leadership
Paul Park, MD, and Madison Michael, MD, were named neurosurgery chair and vice chair at the University of Tennessee Health Science Center College of Medicine’s in Memphis.
Exceptional Women in Medicine Award 2026
Discover the best and brightest, included in the nation’s largest network of peer-nominated doctors.